Omega Fund Management, LLC - JOUNCE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Omega Fund Management, LLC ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$509,699
+66.7%
275,5130.0%0.33%
+222.3%
Q4 2022$305,819
-52.6%
275,5130.0%0.10%
-56.4%
Q3 2022$645,000
-22.8%
275,5130.0%0.24%
-11.6%
Q2 2022$835,000
-55.4%
275,5130.0%0.27%
-30.3%
Q1 2022$1,871,000
-18.7%
275,5130.0%0.38%
+17.8%
Q4 2021$2,301,000
+12.4%
275,5130.0%0.32%
+41.3%
Q3 2021$2,047,000
+9.3%
275,5130.0%0.23%
+8.5%
Q2 2021$1,873,000
-33.8%
275,5130.0%0.21%
-20.9%
Q1 2021$2,830,000
+20.7%
275,513
-17.7%
0.27%
-23.9%
Q4 2020$2,345,000
-14.2%
334,9650.0%0.35%
-52.4%
Q3 2020$2,733,000
-25.3%
334,965
-36.8%
0.74%
-26.1%
Q2 2020$3,657,000
+45.3%
529,9650.0%1.00%
-4.0%
Q1 2020$2,517,000
-45.6%
529,9650.0%1.04%
-29.3%
Q4 2019$4,627,000
+162.2%
529,9650.0%1.47%
+170.3%
Q3 2019$1,765,000
-32.7%
529,9650.0%0.54%
-18.5%
Q2 2019$2,623,000
-60.1%
529,965
-50.0%
0.67%
-51.8%
Q1 2019$6,572,000
+268.0%
1,059,930
+100.0%
1.39%
+4.9%
Q4 2018$1,786,000
-48.2%
529,9650.0%1.32%
-18.8%
Q3 2018$3,445,000
-15.1%
529,9650.0%1.63%
-45.6%
Q2 2018$4,060,000
-65.7%
529,9650.0%3.00%
-74.3%
Q1 2018$11,845,000
+60.3%
529,965
-8.6%
11.64%
+117.8%
Q4 2017$7,391,000
-18.2%
579,6500.0%5.34%
+4.6%
Q3 2017$9,031,000
+11.1%
579,6500.0%5.11%
+0.7%
Q2 2017$8,132,000
-36.2%
579,6500.0%5.08%
-38.8%
Q1 2017$12,747,000579,6508.29%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TRV GP II, LLC 2,697,829$20,045,00088.84%
TRV GP III, LLC 3,048,780$22,652,0004.30%
Logos Global Management LP 2,000,000$14,860,0001.07%
SILVERARC CAPITAL MANAGEMENT, LLC 208,559$1,550,0000.88%
PFM Health Sciences, LP 3,848,822$28,597,0000.84%
Yorktown Management & Research Co Inc 113,200$841,0000.63%
Moloney Securities Asset Management, LLC 282,250$2,097,0000.38%
PATHWAY CAPITAL MANAGEMENT, LP 84,763$630,0000.30%
Sofinnova Investments, Inc. 637,347$4,735,0000.28%
Omega Fund Management, LLC 275,513$2,047,0000.23%
View complete list of JOUNCE THERAPEUTICS INC shareholders